Cancer rarely announces itself until the moment of announcement carries consequence — and it is in this silence that early detection finds its purpose. Dr. Vassily Eliopoulos of Cornell has outlined a framework of screening tests for adults over 35, drawing on decades of established medicine and the emerging science of blood-based detection. The argument is not one of fear, but of foresight: that the most powerful moment to confront illness is before it fully becomes one.
Five Cancer Screening Tests Adults Over 35 Should Consider for Early Detection
Screening exists to catch disease before it becomes disease
Mark
Why does Dr. Eliopoulos think screening matters so much for people over 35 specifically? Is that an arbitrary age?
Mimi
It's not arbitrary. By 35, most people have accumulated enough cellular exposure and time that cancer risk begins to rise meaningfully. It's also the age where preventive medicine shifts from general health to targeted disease prevention.
Luke
But the source doesn't actually explain why 35. It just says "particularly for men and women 35 and above." We don't know if that's based on epidemiology or if it's a practical threshold.
Mark
The Galleri test sounds like a game-changer—screening for 50 cancers at once. Is it replacing the older tests?
Mimi
Not replacing. It's complementary. Colonoscopy and mammography are proven, decades-old tools. Galleri is newer and catches cancers that don't have established screening yet. But it's not diagnostic by itself.
Luke
Right. And the source says it's for "high-risk or proactive adults" to do yearly. That's a qualifier. We don't know how many people actually fit that category, or what the false-positive rate is, or how much it costs.
Mark
What about genetic testing? If someone finds out they carry a BRCA mutation, what actually changes?
Mimi
Everything, potentially. You move from general screening to heightened surveillance tailored to your specific risk. You might consider preventive surgery, more frequent imaging, lifestyle changes. It's personalized medicine.
Luke
The source says genetic testing "allows individuals to tailor surveillance and prevention strategies," but it doesn't detail what those strategies actually are. We know it matters, but not the specifics of how it changes treatment or outcomes.
Mark
So lifestyle factors—sleep, exercise, alcohol, weight—they're as important as the tests themselves?
Mimi
They're foundational. The tests catch what's already developing. Lifestyle shapes whether cancer develops in the first place. They work together.
Luke
The source lists those factors but doesn't quantify their impact. We don't know if they're equally weighted or if one matters more than the others. It's mentioned almost as an afterthought.
The Pulse
- Cancer's quiet progression means that by the time most people feel something is wrong, the window for simpler treatment has often already closed.
- Established tools — colonoscopy from age 45, mammograms from 40, Pap smears from 21, and PSA tests for at-risk men — have decades of evidence behind them and remain the backbone of any screening strategy.
- A new generation of blood tests like Galleri can now scan for signals from more than 50 cancer types at once, offering an early warning system for cancers that have no routine screening protocol at all.
- Genetic testing for mutations like BRCA1, BRCA2, and Lynch syndrome markers transforms inherited uncertainty into a concrete, actionable surveillance plan for high-risk individuals and families.
- Lifestyle factors — alcohol, sleep, exercise, and body weight — are not separate from the screening conversation; they shape the very risk that screening is designed to catch.
Cancer rarely announces itself until the moment of announcement carries consequence — and it is in this silence that early detection finds its purpose. Dr. Vassily Eliopoulos of Cornell has outlined a framework of screening tests for adults over 35, drawing on decades of established medicine and the emerging science of blood-based detection. The argument is not one of fear, but of foresight: that the most powerful moment to confront illness is before it fully becomes one.
Cancer moves quietly, and that silence is its advantage. Dr. Vassily Eliopoulos, an MD at Cornell, has made the case that adults 35 and older should not wait for symptoms to begin the conversation about cancer screening. The goal is not to diagnose disease but to intercept it — to find the precancerous polyp before it turns, or the small tumor before it spreads.
The established tests carry the weight of long evidence. Colonoscopy, starting at 45 and repeated every decade, does more than detect cancer — it removes precancerous growths before they transform. Mammography from age 40 can reveal tumors too small to feel, catching them when treatment is most effective. Pap smears, available since age 21, identify cellular changes before cervical cancer develops. And for men with family history, the PSA test measures a protein that can signal prostate cancer risk.
Beyond these pillars, the field is evolving. Blood tests like Galleri now analyze cell-free DNA to screen for signals from more than 50 cancer types simultaneously — often before any symptoms appear. A positive result is not a diagnosis, but a prompt for further investigation. For high-risk or proactive individuals, Dr. Eliopoulos recommends considering it annually.
Genetic testing adds another dimension. Mutations in BRCA1, BRCA2, CHEK2, and Lynch syndrome markers reveal inherited risk that, once known, can be met with tailored surveillance and preventive strategy. Families with multiple cancer diagnoses or early-onset cases should raise this with their doctor. Whole-body MRI, meanwhile, can scan organs without radiation — though it sometimes surfaces harmless findings that require careful clinical judgment to interpret.
For anyone over 35, Dr. Eliopoulos recommends building a personalized screening schedule that accounts for individual risk, family history, and lifestyle. Alcohol intake, sleep, physical activity, and body weight all shape cancer risk and belong in the same conversation as the tests themselves. Screening and lifestyle are not alternatives — they work together, and neither is sufficient alone.
Cancer moves quietly. By the time symptoms announce themselves, the disease has often advanced beyond the point where treatment becomes straightforward and survival rates begin to narrow. This is why Dr. Vassily Eliopoulos, an MD at Cornell, has made a case for something less dramatic but far more practical: screening tests for adults 35 and older. The logic is simple. Screening exists to catch disease before it becomes disease—to find the precancerous polyp before it turns malignant, to spot the tumor before it causes pain or spreads.
The established tests have decades of evidence behind them. Colonoscopy, recommended starting at age 45 and repeated every ten years, examines the colon and rectum directly. It does more than detect cancer; it finds and removes precancerous growths before they have the chance to transform. For women, mammography beginning at age 40 offers a window into breast tissue without surgery or symptoms. The imaging can reveal tumors too small to feel, catching them at stages where treatment is most effective. Cervical cancer screening through Pap smears—sometimes combined with HPV testing—has been available to women since age 21 and works by identifying cellular changes before cancer develops. For men concerned about prostate cancer, particularly those with family history, the PSA test measures a protein that can signal risk.
But the landscape of cancer detection is shifting. Blood tests now exist that can screen for dozens of cancer types simultaneously by analyzing patterns in cell-free DNA. The Galleri test, for example, can detect signals from more than 50 different cancers, often before any symptoms appear. Dr. Eliopoulos suggests that high-risk or proactive adults consider this test annually, especially for cancers that don't yet have routine screening protocols. It is not diagnostic on its own—a positive result requires follow-up—but it functions as an early warning system that prompts further investigation.
Genetic testing represents another frontier. Mutations in genes like BRCA1, BRCA2, and CHEK2, as well as Lynch syndrome markers, reveal inherited cancer risk. Someone carrying these mutations faces elevated odds, but knowing that fact allows for tailored surveillance and sometimes preventive measures. Families with multiple cancer diagnoses, relatives diagnosed young, or known hereditary syndromes should discuss genetic testing with their doctor. The information transforms uncertainty into actionable strategy.
Whole-body MRI scans the organs without radiation, identifying structural abnormalities that might otherwise go unnoticed. When combined with blood tests or genetic screening, MRI can strengthen confidence in diagnosis and guide whether additional testing is needed. The caveat is real: MRI sometimes finds harmless variations that trigger unnecessary worry or follow-up. Clinical judgment matters.
For anyone over 35 or carrying family history, Dr. Eliopoulos recommends establishing a screening schedule tailored to individual risk. This typically includes routine blood work measuring inflammation and organ function, alongside discussion of newer tests like Galleri and targeted genetic panels. But screening is only part of the equation. Alcohol consumption, sleep quality, physical activity, and body weight all influence cancer risk. These lifestyle factors work in concert with screening—neither replaces the other. The frequency and combination of tests should be determined with a doctor, since risk profiles vary widely from person to person.
Notable Quotes
Early diagnosis and prevention are the only two things that matter before cancer advances to a stage where it becomes difficult to treat— Dr. Vassily Eliopoulos, MD, Cornell
Screening tests are done for a reason—to catch a disease early on for timely prevention— Dr. Vassily Eliopoulos
Want the full story?
Read the original at Times of India ↗
Health & Medicine